Envoy Medical, Inc.
COCHAs of the close on Sep 25, 2026
Price
$0.72
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
Per-share earnings are not available for each of the last four quarters
EPS (TTM)
—
Per-share earnings are not available for each of the last four quarters
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Envoy Medical, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 5 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 23, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 2026-03-31 | 5,665 | Not shown | SEC filing |
| Focus Partners Wealth | 2026-03-31 | 212,655 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 3,000 | Not shown | SEC filing |
| DSG Capital Advisors, LLC | 2026-03-31 | 625,000 | Not shown | SEC filing |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 2026-03-31 | 12,000 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 111,050 | Not shown | SEC filing |
| Bleichroeder LP | 2026-03-31 | 6,250,000 | Not shown | SEC filing |
| LPL Financial LLC | 2026-03-31 | 28,401 | Not shown | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 5 | $3 | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 521,824 | Not shown | SEC filing |
| CIBC Bancorp USA Inc. | 2026-03-31 | 77,887 | Not shown | SEC filing |
| American Capital Advisory, LLC | 2026-03-31 | 2,000 | Not shown | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 47,514 | Not shown | SEC filing |
| METEORA CAPITAL, LLC | 2026-03-31 | 28,051 | Not shown | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 35,297 | Not shown | SEC filing |
| Ballew Advisors, Inc | 2026-03-31 | 10,121 | Not shown | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 73,900 | Not shown | SEC filing |
| CITIGROUP INC | 2026-03-31 | 215 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 23,872 | Not shown | SEC filing |
| Arcus Capital Partners, LLC | 2026-03-31 | 187,573 | Not shown | SEC filing |
- Each value is checked against Envoy Medical, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 19 rows: the value per share could not be confirmed against the share prices on file from within three months of the report date.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- UBS Group AG: 25,418 shares reported 2025-12-31; 70,459 shares reported 2026-03-31.
- WELLS FARGO & COMPANY/MN: 1,738 shares reported 2025-12-31; 1,738 shares reported 2026-03-31.
- BlueStem Wealth Partners, LLC: 10,454 shares reported 2025-12-31; 10,454 shares reported 2026-03-31.
- TWO SIGMA SECURITIES, LLC: 27,656 shares reported 2025-12-31; 23,121 shares reported 2026-03-31.
- Arcus Capital Partners, LLC: 187,573 shares reported 2025-12-31; 187,573 shares reported 2026-03-31.
- STATE STREET CORP: 23,872 shares reported 2025-12-31; 23,872 shares reported 2026-03-31.
- CITIGROUP INC: 1 share reported 2025-12-31; 215 shares reported 2026-03-31.
- Ballew Advisors, Inc: 10,121 shares reported 2025-12-31; 10,121 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 119,115 shares reported 2025-12-31; 35,297 shares reported 2026-03-31.
- METEORA CAPITAL, LLC: 28,051 shares reported 2025-12-31; 28,051 shares reported 2026-03-31.
- BlackRock, Inc.: 39,905 shares reported 2025-12-31; 47,514 shares reported 2026-03-31.
- American Capital Advisory, LLC: 2,000 shares reported 2025-12-31; 2,000 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
17 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Envoy Medical, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-12 · BRYNELSEN CHARLES (derivative): Larger than 11 of the 12 other insider purchases of Warrant (right to buy) on file. SEC filing
- 2026-02-12 · TAYLOR GLEN A: Larger than all 15 other insider purchases of Class A Common Stock on file. SEC filing
- 2026-02-12 · BRYNELSEN CHARLES (derivative): Larger than all 12 other insider purchases of Warrant (right to buy) on file. SEC filing
- 2026-02-12 · BRYNELSEN CHARLES: Larger than 14 of the 15 other insider purchases of Class A Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2026-02-12–2026-02-12: 6 event(s) across 6 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2026-02-12–2026-02-12: 10 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-12 | BRYNELSEN CHARLES · Director | Class A Common Stock | P — Open market or private purchase | +1,000,000 | 0.40 | SEC filing |
| 2026-02-12 | Potashnick Robert · Interim CFO | Warrant (right to buy) | P — Open market or private purchase | +127,500 | 0.00 | SEC filing |
| 2026-02-12 | Lucas Brent T. · Chief Executive Officer | Class A Common Stock | P — Open market or private purchase | +62,500 | 0.40 | SEC filing |
| 2026-02-12 | Patel Mona Chetan · Director | Warrant (right to buy) | P — Open market or private purchase | +187,500 | 0.00 | SEC filing |
| 2026-02-12 | Patel Mona Chetan · Director | Warrant (right to buy) | P — Open market or private purchase | +312,500 | 0.00 | SEC filing |
| 2026-02-12 | Kantor Susan · Director | Warrant (right to buy) | P — Open market or private purchase | +57,690 | 0.00 | SEC filing |
| 2026-02-12 | BRYNELSEN CHARLES · Director | Warrant (right to buy) | P — Open market or private purchase | +1,000,000 | 0.00 | SEC filing |
| 2026-02-12 | Kantor Susan · Director | Class A Common Stock | P — Open market or private purchase | +96,150 | 0.40 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-19 | Lucas Brent T. · Chief Executive Officer | Restricted Stock Units | A — Grant, award, or other acquisition | +1,000,000 | SEC filing |
| 2026-06-19 | Lucas Brent T. · Chief Executive Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +1,000,000 | SEC filing |
| 2026-05-29 | Lucas Brent T. · Chief Executive Officer | Class A Common Stock | A — Grant, award, or other acquisition | +32,856 | SEC filing |
| 2026-04-15 | McKhann Chas · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +100,000 | SEC filing |
| 2026-02-05 | Lucas Brent T. · Chief Executive Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +200,000 | SEC filing |
| 2026-02-05 | Potashnick Robert · Interim CFO | Stock Option (right to buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2025-12-03 | Smith-Gomez Janis · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2025-12-03 | Crowe Michael Curtis · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +25,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-09-04 | TAYLOR GLEN A · Director, 10% owner | Warrant (right to buy) | D — Disposition to the issuer | −250,000 | SEC filing |
| 2025-09-04 | TAYLOR GLEN A · Director, 10% owner | Warrant (right to buy) | D — Disposition to the issuer | −750,000 | SEC filing |
| 2025-09-04 | TAYLOR GLEN A · Director, 10% owner | Warrant (right to buy) | D — Disposition to the issuer | −500,000 | SEC filing |
| 2024-12-23 | Anzu SPAC GP I LLC · 10% owner | Class A Common Stock, par value $0.0001 per share | J — Other acquisition or disposition | −2,028,986 | SEC filing |
| 2024-12-23 | Kantor Susan · Director | Class A Common Stock | J — Other acquisition or disposition | +34,705 | SEC filing |
| 2024-11-19 | Kantor Susan · Director | Class A Common Stock | J — Other acquisition or disposition | +18,182 | SEC filing |
| 2024-11-19 | Anzu SPAC GP I LLC · 10% owner | Class A Common Stock, par value $0.0001 per share | J — Other acquisition or disposition | −1,000,000 | SEC filing |
| 2024-06-24 | Lucas Brent T. · Chief Executive Officer | Class A Common Stock | J — Other acquisition or disposition | +74,784 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.